Sitagliptin in GAD antibody positive diabetes mellitus
Endocrine Practice, 02/08/2012

1 The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM) Acta Diabetologia, April 3, 2012

2 Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes Diabetes/Metabolism Research and Reviews, April 16, 2012

3 Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency Osteoporosis International, March 19, 2012

4 The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial Diabetes Care, April 6, 2012    Clinical Article

5 Vildagliptin effects on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled, type 2 diabetes patients Journal of Diabetes, April 17, 2012    Clinical Article

6 Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria Full Text BMC Pregnancy and Childbirth, April 2, 2012    Free full text

7 Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study Diabetes Care, April 13, 2012

8 Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young Diabetes Care, April 10, 2012

9 Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: use of propensity-score and instrumental variable methods to adjust for treatment-selection bias Pharmacoepidemiology and Drug Safety, April 4, 2012    Clinical Article

10 Which is the preferred angiotensin II receptor blocker-based combination therapy for blood pressure control in hypertensive patients with diabetic and non-diabetic renal impairment? Full Text Cardiovascular Diabetology, April 12, 2012    Free full text

11 Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials Full Text Lipids in Health and Disease, April 5, 2012    Free full text

12 Sleeve Gastrectomy with Jejunal Bypass for the Treatment of Type 2 Diabetes Mellitus in Patients with Body Mass Index <35 kg/m². A cohort study Obesity Surgery, April 30, 2012    Clinical Article

13 Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls Pediatric Diabetes, April 20, 2012

14 Applicability of a Combination of Hemoglobin A1c and Fasting Plasma Glucose in Population-based Prediabetes Screening Journal of Diabetes, April 23, 2012

15 Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy Clinical Endocrinology, April 2, 2012

16 Primary hyperparathyroidism and negative tc99 sestamibi imaging: to operate or not Annals of Surgical Oncology, April 12, 2012

17 Imaging of Thyroid Cancer Seminars in Ultrasound, CT, and MRI, April 3, 2012    Clinical Article

18 Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes Diabetes Care, April 18, 2012    Clinical Article

19 Glycated hemoglobin and cancer incidence and mortality in the atherosclerosis in communities (ARIC) study, 1990-2006 International Journal of Cancer, April 26, 2012

20 Type 2 diabetes managed by diet and lifestyle: HbA1c can identify significant post-prandial hyperglycaemia Practical Diabetes International, April 19, 2012